We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $824M
1-Year Est. Return 78.19%
This Fund
S&P 500
This Quarter Est. Return
+8.25%
1 Year Est. Return
+78.19%
3 Year Est. Return
+156.18%
5 Year Est. Return
+168.38%
10 Year Est. Return
+388.18%
AUM
$652M
AUM Growth
+$21.4M
Cap. Flow
-$20M
Cap. Flow %
-3.06%
Top 10 Hldgs %
31.53%
Holding
180
New
11
Increased
35
Reduced
93
Closed
6

Top Buys

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$3.69M
2
TMP icon
Tompkins Financial
TMP
+$3.57M
3
NTES icon
NetEase
NTES
+$1.96M
4
AMT icon
American Tower
AMT
+$1.8M
5
INST
Instructure Holdings, Inc.
INST
+$1.65M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$7.15M
2
EMR icon
Emerson Electric
EMR
+$6.15M
3
EQNR icon
Equinor
EQNR
+$4.39M
4
NRG icon
NRG Energy
NRG
+$2.72M
5
ES icon
Eversource Energy
ES
+$2.55M

Sector Composition

Rank Sector Weight
1 Technology 31.68%
2 Healthcare 17.44%
3 Industrials 15.98%
4 Utilities 9.18%
5 Energy 5.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EMR icon
1
Emerson Electric
EMR
$86.6B
$34.6M 5.31%
305,319
-59,883
-16% -$6.15M
GLW icon
2
Corning
GLW
$128B
$23.5M 3.61%
713,833
-30,875
-4% -$983K
IBM icon
3
IBM
IBM
$222B
$23.4M 3.59%
122,668
-9,199
-7% -$1.68M
TSM icon
4
TSMC
TSM
$2.17T
$20.7M 3.18%
152,342
-1,200
-0.8% -$149K
OGE icon
5
OGE Energy
OGE
$9.45B
$19.1M 2.93%
556,980
-10,600
-2% -$356K
BMY icon
6
Bristol-Myers Squibb
BMY
$136B
$18.1M 2.77%
333,232
-27,549
-8% -$1.4M
CSCO icon
7
Cisco
CSCO
$433B
$17.9M 2.75%
358,678
-7,188
-2% -$359K
NVS icon
8
Novartis
NVS
$292B
$17.3M 2.66%
179,187
-1,713
-0.9% -$176K
TEL icon
9
TE Connectivity
TEL
$58.7B
$16M 2.46%
110,387
-725
-0.7% -$102K
AVGO icon
10
Broadcom
AVGO
$1.75T
$14.8M 2.27%
111,440
-5,710
-5% -$707K
MSFT icon
11
Microsoft
MSFT
$3.81T
$14.6M 2.24%
34,746
-400
-1% -$162K
SLB icon
12
SLB Ltd
SLB
$85.1B
$14.3M 2.2%
261,604
-3,958
-1% -$200K
INTC icon
13
Intel
INTC
$473B
$14M 2.15%
317,031
-2,600
-0.8% -$116K
AMZN icon
14
Amazon
AMZN
$2.87T
$13.1M 2.01%
72,664
-1,050
-1% -$175K
MRK icon
15
Merck
MRK
$366B
$13M 1.99%
98,199
-600
-0.6% -$74K
XOM icon
16
ExxonMobil
XOM
$644B
$12.6M 1.94%
108,547
-500
-0.5% -$52.3K
MDU icon
17
MDU Resources
MDU
$4.16B
$10.4M 1.59%
742,880
-6,404
-0.9% -$74.1K
DIS icon
18
Walt Disney
DIS
$187B
$9.88M 1.52%
80,724
-2,075
-3% -$217K
PFE icon
19
Pfizer
PFE
$159B
$9.79M 1.5%
352,671
-55,037
-13% -$1.53M
AGX icon
20
Argan
AGX
$5.86B
$7.89M 1.21%
156,129
-6,000
-4% -$281K
AMT icon
21
American Tower
AMT
$82.1B
$7.88M 1.21%
39,881
+9,060
+29% +$1.8M
TMO icon
22
Thermo Fisher Scientific
TMO
$230B
$7.88M 1.21%
13,555
-450
-3% -$253K
BCE icon
23
BCE
BCE
$21.9B
$7.36M 1.13%
216,529
-28,713
-12% -$1.09M
FLS icon
24
Flowserve
FLS
$10.2B
$7.06M 1.08%
154,650
-6,950
-4% -$293K
WDC icon
25
Western Digital
WDC
$166B
$6.96M 1.07%
135,012
-2,249
-2% -$98.5K
1
2 3 4 5

Similar funds

SWIG
Strategic Wealth Investment Group Louisville, Kentucky $825M AUM 11.63% 1-Year Est. Return
RP
Rice Partnership Honolulu, Hawaii $824M AUM 40.45% 1-Year Est. Return
WRPWM
Werba Rubin Papier Wealth Management San Jose, California $824M AUM 24.76% 1-Year Est. Return
IA
Intellus Advisors Naples, Florida $823M AUM 36.99% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $826M AUM 47.87% 1-Year Est. Return
MGAM
McGowan Group Asset Management Dallas, Texas $823M AUM 27.48% 1-Year Est. Return
HVIA
Hudson Valley Investment Advisors Goshen, New York $823M AUM 31.4% 1-Year Est. Return
MWP
Meridian Wealth Partners Exton, Pennsylvania $826M AUM 21.35% 1-Year Est. Return

John G. Ullman & Associates's Q1 2024 Portfolio in Review

As of Q1 2024, John G. Ullman & Associates held 180 positions worth $652M, up 3.4% from $630M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

John G. Ullman & Associates withdrew a net $20M in Q1 2024, closing 6 positions and reducing 93 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.15M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, John G. Ullman & Associates opened a new position in Jazz Pharmaceuticals worth $3.63M.

  • John G. Ullman & Associates's largest Q1 2024 buy was Jazz Pharmaceuticals: 30,150 shares worth $3.63M.
  • John G. Ullman & Associates added most to Tompkins Financial in Q1 2024, an estimated $3.57M increase.
  • John G. Ullman & Associates's biggest Q1 2024 reduction was Emerson Electric, cutting an estimated $6.15M.
  • John G. Ullman & Associates fully exited JPMorgan Chase in Q1 2024, selling an estimated $7.15M.
  • John G. Ullman & Associates's ten largest holdings make up 32% of its $652M portfolio in Q1 2024.
  • John G. Ullman & Associates opened 11 new positions and closed 6 in Q1 2024.
  • John G. Ullman & Associates's portfolio value rose 3.4% quarter-over-quarter to $652M.

Based on John G. Ullman & Associates's 13F filing for Q1 2024, filed 6 May 2024.